Pharmacodynamics of Clonidine Therapy in Pregnancy: A Heterogeneous Maternal Response Impacts Fetal Growth
- 19 August 2010
- journal article
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 23 (11) , 1234-1240
Abstract
Background. Clonidine, a centrally acting antihypertensive agent, has been used successfully in pregnancy. We sought to describe the pharmacodynamic effKeywords
This publication has 15 references indexed in Scilit:
- Clonidine Pharmacokinetics in PregnancyDrug Metabolism and Disposition, 2009
- Maternal Hemodynamic Changes Associated with Furosemide TreatmentHypertension in Pregnancy, 2007
- Detecting Small for Gestational Age Infants: The Development of a Population-Based Reference for Washington StateAmerican Journal of Perinatology, 2005
- Pharmacokinetics and Pharmacodynamics of Atenolol During Pregnancy and PostpartumThe Journal of Clinical Pharmacology, 2005
- Low-dose, short-acting, angiotensin-converting enzyme inhibitors as rescue therapy in pregnancy2000
- Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysisThe Lancet, 2000
- Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension*1Obstetrics & Gynecology, 1999
- The effect of maternal hemodynamics on fetal growth in hypertensive pregnanciesAmerican Journal of Obstetrics and Gynecology, 1991
- MATERNAL HEMODYNAMICS IN NORMAL AND PREECLAMPTIC PREGNANCIES - A LONGITUDINAL-STUDY1990
- Measurement of Cardiac Output in Pregnancy by Doppler TechniqueAmerican Journal of Perinatology, 1990